Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Elsayed Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman MF Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Kamal Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Mohamed Khaleil Heikal, Osama Hetta, Reda Mahmoud ElWakil, Sameh Abdel Wahab, Samir Shehata Eid & Yousri Rostom. (2023) Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1547-1571.
Read now
Read now
Ronald Chow, Charles B. Simone$suffix/text()$suffix/text(), Meghan Pooja Jairam, Anand Swaminath, Gabriel Boldt & Michael Lock. (2022) Radiofrequency ablation vs radiation therapy vs transarterial chemoembolization vs yttrium 90 for local treatment of liver cancer – a systematic review and network meta-analysis of survival data. Acta Oncologica 61:4, pages 484-494.
Read now
Read now
Saito Kobayashi, Kazuto Tajiri, Aiko Murayama, Toshiki Entani, Yuka Futsukaichi, Kohei Nagata, Kosuke Takahashi & Ichiro Yasuda. (2020) Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization. Journal of Hepatocellular Carcinoma 7, pages 181-189.
Read now
Read now
Wei-Shuo Zhang, Xiao-Ou Li, Hui Zhang, Chun Gao, Long Fang & Hua-Yuan Yang. (2020) Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity 13, pages 1979-1988.
Read now
Read now
Articles from other publishers (11)
Anai N. Kothari, Nader N. Massarweh, Madelyn A. Flitcroft, Timothy Newhook, Ching-Wei D. Tzeng, Yun S. Chun, Ahmed O. Kaseb, Jean-Nicolas Vauthey & Hop S. Tran Cao. (2023) Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB.
Crossref
Crossref
Zhongxing Shi, Dongqing Wang, Tanrong Kang, Ru Yi, Liming Cui & Huijie Jiang. (2023)
Comparison of CalliSpheres
®
microspheres drug-eluting beads and conventional transarterial chemoembolization in hepatocellular carcinoma patients: a randomized controlled trial
. Radiology and Oncology 57:1, pages 70-79.
Crossref
Crossref
Jinfeng Kong, Xiuhui Liang, Jinyu Zhang, Jinhua Zeng, Jingfeng Liu & Jianxing Zeng. (2021) Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis. Digestive Diseases and Sciences 67:8, pages 4250-4257.
Crossref
Crossref
Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen & Yuan-Hung Kuo. (2022) Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization. Journal of the Formosan Medical Association 121:4, pages 778-786.
Crossref
Crossref
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou & Moon-Sing Lee. (2021) Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World Journal of Gastroenterology 27:20, pages 2434-2457.
Crossref
Crossref
Lijun Wan, Li Guo, Youwen Hu, Hongyan Huang, Moran Zhang, Kedong Xu, Gejirifu De, Fengfei Zheng, Zhengqiang Wu, Chungen Hu & Zhili Wen. (2021) Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer. Clinical Biochemistry 89, pages 44-50.
Crossref
Crossref
Masatoshi Kudo, Richard S. Finn, Manabu Morimoto, Kun-Ming Rau, Masafumi Ikeda, Chia-Jui Yen, Peter R. Galle, Josep M. Llovet, Bruno Daniele, Ho Yeong Lim, David W. McIlwain, Reigetsu Yoshikawa, Kenichi Nakamura, Kun Liang, Chunxiao Wang, Paolo Abada, Ryan C. Widau & Andrew X. Zhu. (2021) Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2). Liver Cancer 10:5, pages 451-460.
Crossref
Crossref
Qunfang Zhou, Fei Tuo, Ruixia Li, Xiaohui Wang, Juncheng Wang, Zhimei Huang, Minshan Chen & Jinhua Huang. (2020) Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma. Frontiers in Oncology 10.
Crossref
Crossref
Ayman Bannaga & Ramesh P Arasaradnam. (2020) Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 26:33, pages 5022-5049.
Crossref
Crossref
Zhenchang Wang, Yunjie Duan, Jinmei Zhang, Yanhang Lv, Shanshan Wu, Mingrong Cheng, Akshaya Srikanth Bhagavathula, Wafa Ali Aldhaleei, Cain Clark & Zongwei Huo. (2020) Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: A meta-analysis. European Journal of Pharmacology 883, pages 173382.
Crossref
Crossref
Li Wang, Yaqiong Zhan, Zhe Wu, Mengjia Lin, Xuehang Jin, Lushun Jiang & Yunqing Qiu. (2020) A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 125, pages 110033.
Crossref
Crossref